These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33164319)

  • 1. Prevention of long-lasting atrial fibrillation through antitachycardia pacing in DDDR pacemakers.
    Boriani G; Sakamoto Y; Botto G; Komura S; Pieragnoli P; Minamiguchi H; Iacopino S; Noma T; Infusino T; Takahashi Y; Facchin D; De Rosa F; Pisanò E; Meloni S; Biffi M
    Int J Clin Pract; 2021 Mar; 75(3):e13820. PubMed ID: 33164319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial.
    Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G;
    Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial.
    Boriani G; Tukkie R; Manolis AS; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; de Sousa J; Botto GL; Mangoni L; Grammatico A; Padeletti L;
    Eur Heart J; 2014 Sep; 35(35):2352-62. PubMed ID: 24771721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial antitachycardia pacing and atrial remodeling: A substudy of the international, randomized MINERVA trial.
    Boriani G; Tukkie R; Biffi M; Mont L; Ricci R; Pürerfellner H; Botto GL; Manolis AS; Landolina M; Gulizia M; Hudnall JH; Mangoni L; Grammatico A; Padeletti L;
    Heart Rhythm; 2017 Oct; 14(10):1476-1484. PubMed ID: 28506917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.
    Boriani G; Pieragnoli P; Botto GL; Puererfellner H; Mont L; Ziacchi M; Manolis AS; Gulizia M; Tukkie R; Landolina M; Ricciardi G; Cicconelli M; Grammatico A; Biffi M
    Europace; 2019 Apr; 21(4):636-644. PubMed ID: 30649270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.
    Boriani G; Manolis AS; Tukkie R; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; Gulizia M; Samoilenko IV; Wolff C; Holbrook R; Gavazza F; Padeletti L;
    Heart Rhythm; 2015 Jun; 12(6):1192-200. PubMed ID: 25701774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health care cost analysis of enhanced pacing modalities in bradycardia patients: Portuguese case study on the results of the MINERVA trial.
    de Sousa J; Marques P; Martins V; Hipólito-Reis A; Duarte L; Joaquim I; Monteiro D; Boriani G; Wolff C; Grammatico A; Padeletti L
    Rev Port Cardiol (Engl Ed); 2018 Dec; 37(12):973-978. PubMed ID: 30528686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programming Pacemakers to Reduce and Terminate Atrial Fibrillation.
    Pujol-López M; San Antonio R; Tolosana JM; Mont L
    Curr Cardiol Rep; 2019 Sep; 21(10):127. PubMed ID: 31520271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias.
    Funck RC; Boriani G; Manolis AS; Püererfellner H; Mont L; Tukkie R; Pisapia A; Israel CW; Grovale N; Grammatico A; Padeletti L;
    Am Heart J; 2008 Sep; 156(3):445-51. PubMed ID: 18760124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Value of Algorithms of Minimization of Right Ventricular Pacing in Patients With Sick Sinus Syndrome and History of Atrial Fibrillation].
    Ivanchina AE; Kopylov FY; Volkova AL; Samojlenko IV; Syrkin AL
    Kardiologiia; 2018 Aug; (8):58-63. PubMed ID: 30131043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias.
    Lee MA; Weachter R; Pollak S; Kremers MS; Naik AM; Silverman R; Tuzi J; Wang W; Johnson LJ; Euler DE;
    J Am Coll Cardiol; 2003 Jun; 41(11):1926-32. PubMed ID: 12798559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The usefulness of minimal ventricular pacing and preventive AF algorithms in the treatment of PAF: the 'MinVPace' study.
    Veasey RA; Arya A; Freemantle N; Silberbauer J; Patel NR; Lloyd GW; Sulke AN
    J Interv Card Electrophysiol; 2010 Jun; 28(1):51-7. PubMed ID: 20082131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
    Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
    Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between ventricular pacing and persistent atrial fibrillation in patients indicated to elective pacemaker replacement: Results of the Prefer for Elective Replacement MVP (PreFER MVP) randomized study.
    Ricci RP; Botto GL; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Mangoni L; Grammatico A; Kozák M;
    Heart Rhythm; 2015 Nov; 12(11):2239-46. PubMed ID: 26142300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
    Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
    Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of atrial fibrillation in bradyarrhythmias.
    Boriani G; Padeletti L
    Nat Rev Cardiol; 2015 Jun; 12(6):337-49. PubMed ID: 25781413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors and clinical impact of atrial fibrillation after pacemaker implantation in elderly patients treated with dual chamber versus ventricular pacing.
    Stambler BS; Ellenbogen KA; Orav EJ; Sgarbossa EB; Estes NA; Rizo-Patron C; Kirchhoffer JB; Hadjis TA; Goldman L; Lamas GA;
    Pacing Clin Electrophysiol; 2003 Oct; 26(10):2000-7. PubMed ID: 14516342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy.
    Israel CW; Hügl B; Unterberg C; Lawo T; Kennis I; Hettrick D; Hohnloser SH;
    J Cardiovasc Electrophysiol; 2001 Oct; 12(10):1121-8. PubMed ID: 11699520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome.
    Kristensen L; Nielsen JC; Mortensen PT; Pedersen OL; Pedersen AK; Andersen HR
    Heart; 2004 Jun; 90(6):661-6. PubMed ID: 15145874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of AAIR versus DDDR pacing for patients with sinus node dysfunction: a long-term follow-up study.
    Mutagaywa RK; Tumaini B; Chin A
    Cardiovasc J Afr; 2021 Jan-Feb 23; 32(1):17-20. PubMed ID: 32946543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.